28131783|t|Antihyperalgesic effect of CB1 receptor activation involves the modulation of P2X3 receptor in the primary afferent neuron
28131783|a|Cannabinoid system is a potential target for pain control. Cannabinoid receptor 1 (CB1) activation play a role in the analgesic effect of cannabinoids once it is expressed in primary afferent neurons. This study investigates whether the anti-hyperalgesic effect of CB1 receptor activation involves P2X3 receptor in primary afferent neurons. Mechanical hyperalgesia was evaluated by electronic von Frey test. Cannabinoid effect was evaluated using anandamide or ACEA, a non-selective or a selective CB1 receptor agonists, respectively; AM251, a CB1 receptor antagonist, and antisense ODN for CB1 receptor. Calcium imaging assay was performed to evaluated α,β-meATP - responsive cultured DRG neurons pretreated with ACEA. Anandamide or ACEA administered in peripheral tissue reduced the carrageenan -induced mechanical hyperalgesia. The reduction in the carrageenan -induced hyperalgesia induced by ACEA was completely reversed by administration of AM251 as well as by the intrathecal treatment with antisense ODN for CB1 receptor. Also, ACEA reduced the mechanical hyperalgesia induced by bradykinin and by α,β-meATP, a P2X3 receptor non-selective agonist, but not by tumor necrosis factor alpha (TNF-α), interleukin-1 beta (IL-1β) and chemokine -induced chemoattractant-1 (CINC-1). Finally, CB1 receptor s are co-localized with P2X3 receptors in DRG small-diameter neurons and the treatment with ACEA reduced the number of α,β-meATP - responsive cultured DRG neurons. Our data suggest that the analgesic effect of CB1 receptor activation is mediated by a negative modulation of the P2X3 receptor in the primary afferent neurons.
28131783	0	23	Antihyperalgesic effect	T033	C0243095
28131783	27	39	CB1 receptor	T116,T192	C0378126
28131783	40	50	activation	T043	C1514758
28131783	64	74	modulation	UnknownType	C0678672
28131783	78	91	P2X3 receptor	T116,T192	C0382265
28131783	116	122	neuron	T025	C0027882
28131783	123	141	Cannabinoid system	T109,T121	C0006864
28131783	168	180	pain control	T061	C1304888
28131783	182	204	Cannabinoid receptor 1	T116,T192	C0378126
28131783	206	209	CB1	T116,T192	C0378126
28131783	241	257	analgesic effect	T033	C0948482
28131783	261	273	cannabinoids	T109,T121	C0006864
28131783	315	322	neurons	T025	C0027882
28131783	388	400	CB1 receptor	T116,T192	C0378126
28131783	455	462	neurons	T025	C0027882
28131783	464	487	Mechanical hyperalgesia	T184	C2936719
28131783	505	529	electronic von Frey test	T060	C0430022
28131783	531	542	Cannabinoid	T109,T121	C0006864
28131783	570	580	anandamide	T109,T123	C0211726
28131783	584	588	ACEA	T109	C0767833
28131783	621	642	CB1 receptor agonists	T109,T121	C1720260
28131783	658	663	AM251	T109	C0534009
28131783	667	690	CB1 receptor antagonist	T121	C2927149
28131783	696	709	antisense ODN	T114,T123,T130	C0079925
28131783	714	726	CB1 receptor	T116,T192	C0378126
28131783	728	735	Calcium	T121,T123,T196	C0006675
28131783	736	749	imaging assay	T060	C0079595
28131783	777	786	α,β-meATP	T114,T121	C0051285
28131783	789	799	responsive	T169	C0205342
28131783	809	812	DRG	T023	C0017070
28131783	813	820	neurons	T025	C0027882
28131783	837	841	ACEA	T109	C0767833
28131783	843	853	Anandamide	T109,T123	C0211726
28131783	857	861	ACEA	T109	C0767833
28131783	908	919	carrageenan	T109,T121,T123	C0007289
28131783	929	952	mechanical hyperalgesia	T184	C2936719
28131783	975	986	carrageenan	T109,T121,T123	C0007289
28131783	996	1008	hyperalgesia	T184	C2936719
28131783	1020	1024	ACEA	T109	C0767833
28131783	1070	1075	AM251	T109	C0534009
28131783	1094	1115	intrathecal treatment	T061	C2095369
28131783	1121	1134	antisense ODN	T114,T123,T130	C0079925
28131783	1139	1151	CB1 receptor	T116,T192	C0378126
28131783	1159	1163	ACEA	T109	C0767833
28131783	1176	1199	mechanical hyperalgesia	T184	C2936719
28131783	1229	1238	α,β-meATP	T114,T121	C0051285
28131783	1242	1255	P2X3 receptor	T116,T192	C0382265
28131783	1270	1277	agonist	T109,T121	C1720260
28131783	1290	1317	tumor necrosis factor alpha	T116,T129	C1456820
28131783	1319	1324	TNF-α	T116,T129	C1456820
28131783	1327	1345	interleukin-1 beta	T116,T129	C0021753
28131783	1347	1352	IL-1β	T116,T129	C0021753
28131783	1358	1367	chemokine	T116,T129	C0282554
28131783	1377	1394	chemoattractant-1	T116,T123	C0033684
28131783	1396	1402	CINC-1	T116,T123	C0033684
28131783	1414	1426	CB1 receptor	T116,T192	C0378126
28131783	1451	1465	P2X3 receptors	T116,T192	C0382265
28131783	1469	1472	DRG	T023	C0017070
28131783	1488	1495	neurons	T025	C0027882
28131783	1519	1523	ACEA	T109	C0767833
28131783	1546	1555	α,β-meATP	T114,T121	C0051285
28131783	1558	1568	responsive	T169	C0205342
28131783	1578	1581	DRG	T023	C0017070
28131783	1582	1589	neurons	T025	C0027882
28131783	1617	1633	analgesic effect	T033	C0948482
28131783	1637	1649	CB1 receptor	T116,T192	C0378126
28131783	1650	1660	activation	T043	C1514758
28131783	1678	1697	negative modulation	UnknownType	C0678672
28131783	1705	1718	P2X3 receptor	T116,T192	C0382265
28131783	1743	1750	neurons	T025	C0027882